Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence.
Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic's Evolut TAVR platform performs as well as SAVR—and even better in some ways.
Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels.
India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients.
A Cleveland Clinic researcher accepted NIH funding without telling the agency about money coming in for the same project from one or more foreign backers. For this the nonprofit Cleveland Clinic Foundation will pay $7.6 million.
Up to 30% of patients have metastatic disease by the time they are initially diagnosed with renal cell carcinoma, making accurate staging a critical element of treatment planning.
Experts have identified numerous white matter features, in addition to changes in white matter tracts that occur over time, which they believe are more common among people with ADHD.
